Nike's Plunge Highlights Turnaround Pain as Revenue Decline Persists

What happened

Nike shares have fallen 77% over five years, reflecting multiple guidance cuts, while the company now expects FY2027 revenue to decline high-single-digits. Q1 FY2027 revenue fell 5% currency-neutral to $11.2B, with Greater China down 26% and Direct down 9%, though North America wholesale rose 9%. Gross margin improved to 42.8% driven by lower logistics costs rather than pricing, and inventory rose sequentially to $7.8B. The turnaround timeline has extended beyond fiscal 2027 for China, Sportswear, and Jordan, with Pace restructuring targeting $2.5B cumulative savings through FY31. The stock trades near $34, above our $30 attractive entry, still priced at 16.4x P/E and 12.1x EV/EBITDA.

Implication

Our WAIT rating reflects that the stock is not yet cheap enough to offset a multiquarter decline, with base case fair value near $35 and bear case $28. The next catalysts are Investor Day on Nov 16-17, 2026, and subsequent quarterly filings that must show wholesale turning positive and Direct declines narrowing. If China wholesale fails to improve from -31% and inventory keeps rising, downside risk to $28 becomes likely. Conversely, a re-rate toward $43 requires consolidated wholesale growth and clear sell-through improvement in Sportswear/Jordan by spring 2027. We recommend scaling in only below $30 or after proof of China stabilization and Direct repair.

Thesis delta

The thesis remains unchanged: Nike's brand moat is intact in North America and performance categories, but the turnaround is delayed and guidance for high-single-digit revenue decline confirms the under-earning period will persist. The new article adds no material information beyond highlighting the 77% stock decline and reiterated guidance, which reinforces our WAIT stance and $30 entry threshold. No upgrade is warranted until we see observable demand repair in China and Direct.